LATEST NEWS AND ARTICLES

From events, scientific articles to PR, you will find here all our latest news.

TERMIS 2024

7th TERMIS World Congress in Seattle, USA, to discuss the latest advancements in tissue engineering and regenerative medicine !

HVD Life Science and Poietis announce a distribution partnership for Poietis’ NGB-R platform

Poietis and HVD Life Sciences are pleased to announce the signature of their collaboration for the distribution of Poietis’ Next-Generation Bioprinting (NGB) platform designed for translational research in Austria and Germany.

👩🏻‍🔬 Revolutionizing Organ-on-Chip Models with Next-Generation Bioprinting

Poietis's NGB platform, offers unparalleled precision in 3D bioprinting, addressing key challenges in organ-on-chip (OoC) development.

🧠 Poietis Partners in the Groundbreaking 4-DBR Project

We are proud to be partner in the 4-Deep Brain Reconstruction (4-DBR) initiative, a Horizon European Innovation Council (EIC) Pathfinder Open project aimed at revolutionizing the treatment of neurodegenerative disorders.

🔬 Exciting Times in Stem Cell Research! 🧠

The French Society for Stem Cell Research (@FSSCR) recently concluded a three-day conference, drawing over 300 participants deeply engaged in the latest stem cell research developments.

Poietis announces formation of Scientific Advisory Board and appoints two first prominent Regenerative Medicine experts

Poietis, 4D Bioprinting company, announces formation of Scientific Advisory Board (SAB) and appointment of two first prominent Scientists in Regenerative Medicine: Dr. Gurtner and Dr. May

Poietis signs a clinical research collaboration contract with the Assistance Publique – Hôpitaux de Marseille (AP-HM)

Poietis, leading bioprinting company, and the « Assistance Publique – Hôpitaux de Marseille » (AP-HM) announced today that they have entered into a partnership through the signature the 20th of January of a clinical research collaboration contract on a bioprinted tissue engineering product.

Bioprinting: Poietis announces the award of a third new major European patent

Poietis, 4D Bioprinting company, announces the issuance by the European Patent Office of a third patent covering its bioprinting technology: Patent No. EP3233499 entitled «Laser printing method and device for implementing said method».

Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues

Servier, an independent international pharmaceutical company, and Poietis, a leader in the production of living bioprinted tissues, have announced a scientific partnership to use Poietis’s 4D bioprinting technology for the development and production of liver tissues.

Poietis launches its new 4D Bioprinting platform

Poietis, the first 4D bioprinting company, announces the commercialization of its new range of NGB systems («Next Generation Bioprinting») to cover all the tissue engineering needs, from research to clinical batches production.

Do you want to know more about NGB platform?